# An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face

> **NCT02403986** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 53 (actual)

## Conditions studied

- Aged Skin

## Interventions

- **DEVICE:** Restylane Vital Skinboosters Lidocaine

## Key facts

- **NCT ID:** NCT02403986
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-03-30
- **Final completion:** 2017-03-30
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02403986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02403986, "An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02403986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*